Roschier advises in Moberg Pharma OTC acquisition
Roschier represented a holding company owned by RoundTable Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, and Signet Healthcare Partners, an established provider of growth capital to innovative healthcare companies, in the USD 155 million acquisition of Moberg Pharma’s OTC-business and the contemplated subscription of newly issued series B shares and warrants in Moberg Pharma. Moberg Pharma is a Swedish pharmaceutical company listed on Nasdaq Stockholm.
The acquisition is conditional upon shareholder approval at a general meeting in Moberg Pharma.
The Roschier team mainly comprised Ola Sandersson, Malin Leffler, Erik Persson, Jenny Welander Wadström, David Antonovic, Emmy Pettersson, Emelie Löfgren, Therese Almgren, and Oliver Bengtsar Sellner.